Lopez-Fabuel Irene, Resch-Beusher Monica, Carabias-Carrasco Monica, Almeida Angeles, Bolaños Juan P
Institute of Functional Biology and Genomics (IBFG), University of Salamanca-CSIC, Zacarias Gonzalez, 2, 37007, Salamanca, Spain.
Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, 37007, Salamanca, Spain.
Neurochem Res. 2017 Jun;42(6):1676-1682. doi: 10.1007/s11064-017-2191-2. Epub 2017 Feb 14.
The assembly of complex I (CI) with complexes III (CIII) and IV (CIV) of the mitochondrial respiratory chain (MRC) to configure I-III- or I-III-IV-containing supercomplexes (SCs) regulates mitochondrial energy efficiency and reactive oxygen species (mROS) production. However, whether the occurrence of SCs impacts on CI specific activity remains unknown to our knowledge. To investigate this issue, here we determined CI activity in primary neurons and astrocytes, cultured under identical antioxidants-free medium, from two mouse strains (C57Bl/6 and CBA) and Wistar rat, i.e. three rodent species with or without the ability to assemble CIV into SCs. We found that CI activity was 6- or 1.8-fold higher in astrocytes than in neurons, respectively, from rat or CBA mouse, which can form I-III-IV SC; however, CI activity was similar in the cells from C57Bl/6 mouse, which does not form I-III-IV SC. Interestingly, CII-III activity, which was comparable in neurons and astrocytes from mice, was about 50% lower in astrocytes when compared with neurons from rat, a difference that was abolished by antioxidants- or serum-containing media. CIV and citrate synthase activities were similar under all conditions studied. Interestingly, in rat astrocytes, CI abundance in I-III-IV SC was negligible when compared with its abundance in I-III-containing SCs. Thus, CIV-containing SCs formation may determine CI specific activity in astrocytes, which is important to understand the mechanism for CI deficiency observed in Parkinson's disease.
线粒体呼吸链(MRC)的复合物I(CI)与复合物III(CIII)和IV(CIV)组装形成含I-III或I-III-IV的超复合物(SC),可调节线粒体能量效率和活性氧(mROS)生成。然而,据我们所知,SC的出现是否会影响CI的比活性仍不清楚。为了研究这个问题,我们在相同的无抗氧化剂培养基中培养来自两种小鼠品系(C57Bl/6和CBA)和Wistar大鼠(即三种有无能力将CIV组装到SC中的啮齿动物物种)的原代神经元和星形胶质细胞,测定了CI活性。我们发现,来自大鼠或CBA小鼠(可形成I-III-IV SC)的星形胶质细胞中的CI活性分别比神经元高6倍或1.8倍;然而,来自不形成I-III-IV SC的C57Bl/6小鼠的细胞中CI活性相似。有趣的是,小鼠神经元和星形胶质细胞中相当的CII-III活性,与大鼠神经元相比,星形胶质细胞中的CII-III活性低约50%,这种差异在含抗氧化剂或血清的培养基中消失。在所有研究条件下,CIV和柠檬酸合酶活性相似。有趣的是,在大鼠星形胶质细胞中,与含I-III的SC相比,I-III-IV SC中CI的丰度可忽略不计。因此,含CIV的SC的形成可能决定星形胶质细胞中CI的比活性,这对于理解帕金森病中观察到的CI缺乏机制很重要。